drugset / Trial / NCT02970929
An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia
NaSingle-groupOpen-labelTreatment
Summary
An extension study of safety and tolerability of SEP-363856 in adult subjects with schizophrenia
Timeline
- Start
- 2017-01-31
- Primary completion
- 2019-01-29
- Completion
- 2019-01-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ulotaront | Small molecule | 25 mg | — |
| Subject | Ulotaront | Small molecule | 50 mg | — |
| Subject | Ulotaront | Small molecule | 75 mg | — |